Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Clinical Diagnostics Insider
Keeps you up-to-date on new diagnostic tests, testing trends and opportunities, and emerging test technologies
Virtual Events & Webinars
Virtual events & webinars offer a variety of solutions and strategies for dealing with key issues labs face.
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
Americans Awareness of Genetic Testing Increasing, Survey Finds
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies A new survey shows 73 percent of Americans are aware of genetic testing for hereditary cancers—a significant increase over just a few years ago that is largely attributed to the "Angelina...
3…2…1… ICD-10 Launches This Week
By Kelly A. Briganti, Editorial Director, G2 Intelligence Ready, set, go. ICD-10 implementation finally becomes a reality this Thursday on October 1, 2015. Centers for Medicare & Medicaid Services' ICD-10 Ombudsman Dr. Bill Rogers issued a press release last...
DOJ Memo Emphasizes Focus on Individual Liability for Corporate Misconduct
...
CMTP Issues Draft Framework for Covering NGS Testing
...
Two FDA Workshops Focus on Precision Medicine Issues
...
New FDA Advisory Committee Gives Patients a Voice in Device Approval Process
By Kelly A. Briganti, Editorial Director, G2 Intelligence Recognizing the shift to "patient-centered medicine," the U.S. Food and Drug Administration (FDA) announced last week the first-ever Patient Engagement Advisory Committee (PEAC), advising the FDA...
Novel Tests May Earlier ID Those at Risk of Suicide, Postpartum Depression
...
Universal Drug Testing at Delivery Aids Infants
...
AACR Calls to Up Federal Research Funding by 7% to Further Drive Personalized Oncology Care
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Enhanced federal investment in cancer research is both necessary and supported by the American public, according to the new report Cancer Progress Report 2015: Transforming Lives Through...